Previous Article | Next Article 
Antimicrob Agents Chemother. 1985 June; 27(6): 921-924
Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis.
T Yamada,
A Nagata,
Y Ono,
Y Suzuki and
T Yamanouchi
ABSTRACT
The biochemical mechanism of resistance to kanamycin, viomycin, and rifampin in five clinical isolates of Mycobacterium tuberculosis was studied. Resistance to viomycin and kanamycin was attributed to altered ribosomes, whereas resistance to rifampin was attributed to an alteration of RNA polymerase. Ribosomal resistance was, however, not the only way of expressing resistance to viomycin and kanamycin.
Antimicrob Agents Chemother. 1985 June; 27(6): 921-924
This article has been cited by other articles:
-
Felnagle, E. A., Rondon, M. R., Berti, A. D., Crosby, H. A., Thomas, M. G.
(2007). Identification of the Biosynthetic Gene Cluster and an Additional Gene for Resistance to the Antituberculosis Drug Capreomycin. Appl. Environ. Microbiol.
73: 4162-4170
[Abstract]
[Full Text]
-
Maus, C. E., Plikaytis, B. B., Shinnick, T. M.
(2005). Mutation of tlyA Confers Capreomycin Resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother.
49: 571-577
[Abstract]
[Full Text]
-
Piddock, L. J. V., Williams, K. J., Ricci, V.
(2000). Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis. J Antimicrob Chemother
45: 159-165
[Abstract]
[Full Text]